Stroma-driven horizontal transfer of TCA-related proteins mediates metabolic plasticity and imatinib resistance in chronic myeloid leukemia

This study describes a novel mechanism of direct bone marrow-mediated protection of leukemic cells from imatinib/TKI, related to transfer of metabolic proteins leading to higher activity of TCA cycle, metabolic plasticity and adaptation. Targeting the stroma-driven TCA cycle-related metabolism combined with imatinib presents a promising strategy to achieve therapeutic efficacy to overcome bone marrow microenvironment-mediated protection in CML.

Authors

Institutions

Publication Details

Journal
Cell Communication and Signaling
Published
2025-12-02
DOI
https://doi.org/10.1186/s12964-025-02564-7
Citations
1
Primary Topic
Chronic Myeloid Leukemia Treatments
Type
article
Field-Weighted Citation Impact
1.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stroma-driven horizontal transfer of TCA-related proteins mediates metabolic plasticity and imatinib resistance in chronic myeloid leukemia

Magdalena Lebiedzińska, Dominik Cysewski, Krzysztof Zabłocki, Dawid Stępnik et al.
1 citations
Cell Communication and Signaling
Chronic Myeloid Leukemia Treatments
1.77
article

Stroma-driven horizontal transfer of TCA-related proteins mediates metabolic plasticity and imatinib resistance in chronic myeloid leukemia

Magdalena Lebiedzińska, Dominik Cysewski, Krzysztof Zabłocki, Dawid Stępnik, Monika Kusio-Kobiałka, Dorota Dymkowska, Vira Chumak, Piotr Chrościcki, Alicja Krop, Mariusz R. Wiȩckowski, Nikodem Kasak, Katarzyna Piwocka, Laura Turos-Korgul, Tomasz Stokłosa, Agata Kominek, Joanna Szczepanowska
article en
1 citations

Abstract

This study describes a novel mechanism of direct bone marrow-mediated protection of leukemic cells from imatinib/TKI, related to transfer of metabolic proteins leading to higher activity of TCA cycle, metabolic plasticity and adaptation. Targeting the stroma-driven TCA cycle-related metabolism combined with imatinib presents a promising strategy to achieve therapeutic efficacy to overcome bone marrow microenvironment-mediated protection in CML.

Cell Communication and SignalingVol. 24(1)
Medical University of Białystok (PL), Instytut Biologii Doświadczalnej im. Marcelego Nenckiego (PL), Medical University of Warsaw (PL), Polish Academy of Sciences (PL)
Openalex Percentile: Top 11%
Chronic Myeloid Leukemia Treatments
1.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.